Incremental cost-effectiveness ratios (ICER) over all scenarios (mean values). | ORKG Ask

We use cookies to provide a better user experience.

Data Protection

Related items

Mean and median incremental cost-effectiveness ratios (cost per DALY averted) with parameters varied, by age group and vial size (US$).

Ashraful Islam Khan (236188)
Ann Levin (361456)
Dennis L. Chao (119857)
Denise DeRoeck (5832239)
Dobromir T. Dimitrov (669490)
Jahangir A. M. Khan (632407)
Muhammad Shariful Islam (5832242)
Mohammad Ali (73095)
Md. Taufiqul Islam (5832245)
Abdur Razzaque Sarker (2167912)
John D. Clemens (148728)
Firdausi Qadri (89170)

October 2018

Mean and median incremental cost-effectiveness ratios (cost per DALY averted) with parameters varied...

Incremental cost-effectiveness plane (left) and cost-effectiveness acceptability curve (right) for cost per QALY, showing 5000 bootstrapped cost-effectiveness pairs.

Ben F. M. Wijnen (4997315)
Bea Hemmen (3633202)
Ans I. E. Bouman (3633208)
Henk van de Meent (731131)
Ton Ambergen (295464)
Peter R. G. Brink (3633211)
Henk A. M. Seelen (563131)
Silvia M. A. A. Evers (643477)

March 2019

PE-line: line which represents the point estimate of the ICER (average cost/effect of bootstrap repl...

Incremental cost effectiveness ratio plan, presenting the results of the probabilistic sensitivity analysis of LPV/r vs. ATV+r 1 regimens.

Emanuela Foglia (383172)
Paolo Bonfanti (383173)
Giuliano Rizzardini (103636)
Erminio Bonizzoni (383174)
Umberto Restelli (383175)
Elena Ricci (316160)
Emanuele Porazzi (383176)
Francesca Scolari (127986)
Davide Croce (383177)

February 2013

<p>Incremental cost effectiveness ratio plan, presenting the results of the probabilistic sensitivit...

Analyses of incremental cost-effectiveness ratios (ICERs) based on age and risk groups.

Jung Yeon Heo (583953)
Yu Bin Seo (409861)
Won Suk Choi (409867)
Jacob Lee (409868)
Ji Yun Noh (409863)
Hye Won Jeong (409869)
Woo Joo Kim (409870)
Min Ja Kim (575028)
Hee Young Lee (442609)
Joon Young Song (409859)

May 2017

<p>Analyses of incremental cost-effectiveness ratios (ICERs) based on age and risk groups.</p

Cost-utility analysis: Incremental cost-effectiveness ratio (ICER)—base case.

Denise Howel (16468)
Suzanne Moffatt (16467)
Catherine Haighton (2157001)
Andrew Bryant (5704967)
Frauke Becker (2836922)
Melanie Steer (6194798)
Sarah Lawson (6194801)
Terry Aspray (6194804)
Eugene M. G. Milne (2215138)
Luke Vale (3435356)
Elaine McColl (533649)
Martin White (16466)

January 2019

Cost-utility analysis: Incremental cost-effectiveness ratio (ICER)—base case.</p

Total cost, cases detected, incremental costs, incremental cases detected and incremental cost effectiveness ratio (ICER).

Brandon S. Walker (764525)
Richard E. Nelson (764526)
Brian R. Jackson (233567)
David G. Grenache (764527)
Edward R. Ashwood (764528)
Robert L. Schmidt (764529)

July 2015

<p>Total cost, cases detected, incremental costs, incremental cases detected and incremental cost ef...

Incremental Cost-Effectiveness Ratio (ICER) according to different treatment completion rates in DOT facilities.

Ricardo Steffen (359737)
Dick Menzies (66118)
Olivia Oxlade (66115)
Marcia Pinto (5653372)
Analia Zuleika de Castro (359738)
Paula Monteiro (359739)
Anete Trajman (359740)

February 2013

<p>The incremental cost-effectiveness ratio was calculated according to an increasing treatment comp...

Cost-effectiveness outcomes for all pregnant women and first-generation non-Western women (scenarios 1a and 1b), based on probabilistic uncertainty analysis (10000 simulations).

Anouk T. Urbanus (344230)
Marjolijn van Keep (444487)
Amy A. Matser (444488)
Mark H. Rozenbaum (444489)
Christine J. Weegink (313620)
Anneke van den Hoek (246127)
Maria Prins (339491)
Maarten J. Postma (239601)

August 2013

<p>The incremental cost-effectiveness ratio (ICER) is calculated with reference to the “no routine s...

Incremental cost-effectiveness plane (left) and cost-effectiveness acceptability curve (right) for cost per point improvement on the FIM, showing 5000 bootstrapped cost-effectiveness pairs.

Ben F. M. Wijnen (4997315)
Bea Hemmen (3633202)
Ans I. E. Bouman (3633208)
Henk van de Meent (731131)
Ton Ambergen (295464)
Peter R. G. Brink (3633211)
Henk A. M. Seelen (563131)
Silvia M. A. A. Evers (643477)

March 2019

PE-line: line which represents the point estimate of the ICER (average cost/effect of bootstrap repl...

Mean and median incremental cost-effectiveness ratios (cost per DALY averted) with parameters varied, by age group and vial size (US$).

Ashraful Islam Khan (236188)
Ann Levin (361456)
Dennis L. Chao (119857)
Denise DeRoeck (5832239)
Dobromir T. Dimitrov (669490)
Jahangir A. M. Khan (632407)
Muhammad Shariful Islam (5832242)
Mohammad Ali (73095)
Md. Taufiqul Islam (5832245)
Abdur Razzaque Sarker (2167912)
John D. Clemens (148728)
Firdausi Qadri (89170)

October 2018

Mean and median incremental cost-effectiveness ratios (cost per DALY averted) with parameters varied...

Incremental cost-effectiveness plane (left) and cost-effectiveness acceptability curve (right) for cost per QALY, showing 5000 bootstrapped cost-effectiveness pairs.

Ben F. M. Wijnen (4997315)
Bea Hemmen (3633202)
Ans I. E. Bouman (3633208)
Henk van de Meent (731131)
Ton Ambergen (295464)
Peter R. G. Brink (3633211)
Henk A. M. Seelen (563131)
Silvia M. A. A. Evers (643477)

March 2019

PE-line: line which represents the point estimate of the ICER (average cost/effect of bootstrap repl...

Incremental cost effectiveness ratio plan, presenting the results of the probabilistic sensitivity analysis of LPV/r vs. ATV+r 1 regimens.

Emanuela Foglia (383172)
Paolo Bonfanti (383173)
Giuliano Rizzardini (103636)
Erminio Bonizzoni (383174)
Umberto Restelli (383175)
Elena Ricci (316160)
Emanuele Porazzi (383176)
Francesca Scolari (127986)
Davide Croce (383177)

February 2013

<p>Incremental cost effectiveness ratio plan, presenting the results of the probabilistic sensitivit...

Cost-utility analysis: Incremental cost-effectiveness ratio (ICER)—base case.

Denise Howel (16468)
Suzanne Moffatt (16467)
Catherine Haighton (2157001)
Andrew Bryant (5704967)
Frauke Becker (2836922)
Melanie Steer (6194798)
Sarah Lawson (6194801)
Terry Aspray (6194804)
Eugene M. G. Milne (2215138)
Luke Vale (3435356)
Elaine McColl (533649)
Martin White (16466)

January 2019

Cost-utility analysis: Incremental cost-effectiveness ratio (ICER)—base case.</p

Incremental Cost-Effectiveness Ratio (ICER) according to different treatment completion rates in DOT facilities.

Ricardo Steffen (359737)
Dick Menzies (66118)
Olivia Oxlade (66115)
Marcia Pinto (5653372)
Analia Zuleika de Castro (359738)
Paula Monteiro (359739)
Anete Trajman (359740)

February 2013

<p>The incremental cost-effectiveness ratio was calculated according to an increasing treatment comp...

Cost-effectiveness outcomes for all pregnant women and first-generation non-Western women (scenarios 1a and 1b), based on probabilistic uncertainty analysis (10000 simulations).

Anouk T. Urbanus (344230)
Marjolijn van Keep (444487)
Amy A. Matser (444488)
Mark H. Rozenbaum (444489)
Christine J. Weegink (313620)
Anneke van den Hoek (246127)
Maria Prins (339491)
Maarten J. Postma (239601)

August 2013

<p>The incremental cost-effectiveness ratio (ICER) is calculated with reference to the “no routine s...

Incremental cost-effectiveness plane (left) and cost-effectiveness acceptability curve (right) for cost per point improvement on the FIM, showing 5000 bootstrapped cost-effectiveness pairs.

Ben F. M. Wijnen (4997315)
Bea Hemmen (3633202)
Ans I. E. Bouman (3633208)
Henk van de Meent (731131)
Ton Ambergen (295464)
Peter R. G. Brink (3633211)
Henk A. M. Seelen (563131)
Silvia M. A. A. Evers (643477)

March 2019

PE-line: line which represents the point estimate of the ICER (average cost/effect of bootstrap repl...

Mean and median incremental cost-effectiveness ratios (cost per DALY averted) with parameters varied, by age group and vial size (US$).

Ashraful Islam Khan (236188)
Ann Levin (361456)
Dennis L. Chao (119857)
Denise DeRoeck (5832239)
Dobromir T. Dimitrov (669490)
Jahangir A. M. Khan (632407)
Muhammad Shariful Islam (5832242)
Mohammad Ali (73095)
Md. Taufiqul Islam (5832245)
Abdur Razzaque Sarker (2167912)
John D. Clemens (148728)
Firdausi Qadri (89170)

October 2018

Mean and median incremental cost-effectiveness ratios (cost per DALY averted) with parameters varied...

Incremental cost-effectiveness plane (left) and cost-effectiveness acceptability curve (right) for cost per QALY, showing 5000 bootstrapped cost-effectiveness pairs.

Ben F. M. Wijnen (4997315)
Bea Hemmen (3633202)
Ans I. E. Bouman (3633208)
Henk van de Meent (731131)
Ton Ambergen (295464)
Peter R. G. Brink (3633211)
Henk A. M. Seelen (563131)
Silvia M. A. A. Evers (643477)

March 2019

PE-line: line which represents the point estimate of the ICER (average cost/effect of bootstrap repl...

Incremental cost effectiveness ratio plan, presenting the results of the probabilistic sensitivity analysis of LPV/r vs. ATV+r 1 regimens.

Emanuela Foglia (383172)
Paolo Bonfanti (383173)
Giuliano Rizzardini (103636)
Erminio Bonizzoni (383174)
Umberto Restelli (383175)
Elena Ricci (316160)
Emanuele Porazzi (383176)
Francesca Scolari (127986)
Davide Croce (383177)

February 2013

<p>Incremental cost effectiveness ratio plan, presenting the results of the probabilistic sensitivit...